Calculation of your study is finished. Please find your results below.

A study for a 43 year old man who takes Glutathione (an AI-powered real world drug study)

Summary:

88 males aged 43 (±5) who take the same drug and have adverse effects are studied. This is a phase IV clinical study for a 43 year old male patient who has White Blood Cell Analysis Decreased. The study is created by eHealthMe based on reports from sources including the FDA.


On Aug, 03, 2026

88 males aged 43 (±5) who take Glutathione and have adverse effects are studied.


Number of reports submitted per year:

Glutathione for a 43-year old man.

Information of the patient in this study:

  • Age: 43
  • Gender: male

What are the drugs?

What are the conditions?

What are the adverse effects?


Comparison with patient's specific adverse outcomes:

You can check what is more associated with an adverse outcome: a drug mix, a drug, a condition, or a population of certain gender and age. Each patient is different. It is not uncommon that the results can be inconclusive or insignificant.

By the same drug(s):

  • White Blood Cell Analysis Decreased:
    - among males aged 43 (±5) who take the same drug: 0% (0 of 88)
    - among people who take the same drug, regardless of gender or age: 0% (0 of 2,147)

By each condition:


By each drug (FDA data only):

  • people who take Glutathione and have White Blood Cell Analysis Decreased:
    - among males aged 43 (±5) who take Glutathione and have side effects: 0% (0 of 84)
    - among people who take Glutathione and have side effects, regardless of gender or age: 0% (0 of 1,987)

Common side effects *:

  1. Thrombocytopenia (decrease of platelets in blood): 18 people, 20.45%
  2. Blood Glucose Increased : 10 people, 11.36%
  3. Lymphocyte Count Decreased : 10 people, 11.36%
  4. Fever : 8 people, 9.09%
  5. Haemoglobin Decreased : 8 people, 9.09%
  6. Incision Site Pain : 8 people, 9.09%
  7. Blood Urea Increased : 8 people, 9.09%
  8. Anaemia (lack of blood): 7 people, 7.95%
  9. High Blood Cholesterol : 7 people, 7.95%
  10. Neutrophil Count Increased (excess than normal number of neutrophil a type of blood cell): 7 people, 7.95%
  11. Blood Bilirubin Increased : 6 people, 6.82%
  12. White Blood Cell Count Increased : 6 people, 6.82%
  13. Alanine Aminotransferase Increased : 6 people, 6.82%
  14. Hypotension (abnormally low blood pressure): 5 people, 5.68%
  15. Aspartate Aminotransferase Increased : 5 people, 5.68%
  16. Hepatic Function Abnormal : 5 people, 5.68%
  17. Bilirubin Conjugated Increased : 5 people, 5.68%
  18. Transaminases Increased : 5 people, 5.68%
  19. Productive Cough : 5 people, 5.68%
  20. Pneumonia : 4 people, 4.55%

Common co-existing conditions *:

You may use this to check any potential undetected conditions.

  1. High Blood Pressure : 18 people, 20.45%
  2. Urination - Excessive Volume : 15 people, 17.05%
  3. Productive Cough : 11 people, 12.50%
  4. Multiple Myeloma (cancer of the plasma cells): 9 people, 10.23%
  5. Cough : 8 people, 9.09%
  6. Hepatitis B : 8 people, 9.09%
  7. Wheezing (a high-pitched whistling sound made while you breath): 6 people, 6.82%
  8. Inflammation : 6 people, 6.82%
  9. Anaemia (lack of blood): 6 people, 6.82%
  10. Immunodeficiency Disorders : 6 people, 6.82%
  11. Cardiovascular Insufficiency (inadequate functioning of heart): 6 people, 6.82%
  12. Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 6 people, 6.82%
  13. Sedation : 6 people, 6.82%
  14. Psoriasis (immune-mediated disease that affects the skin): 5 people, 5.68%
  15. Haemostasis (stopping of bleeding): 5 people, 5.68%
  16. Insomnia (sleeplessness): 5 people, 5.68%
  17. Nausea And Vomiting : 5 people, 5.68%
  18. Thrombocytopenia (decrease of platelets in blood): 5 people, 5.68%
  19. Infection : 5 people, 5.68%
  20. Asthma : 5 people, 5.68%

Common co-used drugs *:

You may use this to check any potential interacting drugs.

  1. Myfortic (18 people, 20.45%)
  2. Sodium Chloride (11 people, 12.50%)
  3. Vitamin B6 (11 people, 12.50%)
  4. Potassium Chloride (9 people, 10.23%)
  5. Cisplatin (7 people, 7.95%)
  6. Carfilzomib (7 people, 7.95%)
  7. Dexamethasone Sodium Phosphate (7 people, 7.95%)
  8. Pantoprazole (6 people, 6.82%)
  9. Vitamin C (6 people, 6.82%)
  10. Furosemide (6 people, 6.82%)
  11. Methylprednisolone (6 people, 6.82%)
  12. Calcium (6 people, 6.82%)
  13. Ciclosporin (5 people, 5.68%)
  14. Scopolamine (5 people, 5.68%)
  15. Oxaliplatin (5 people, 5.68%)
  16. Zoledronic Acid (5 people, 5.68%)
  17. Dexamethasone (5 people, 5.68%)
  18. Micafungin Sodium (5 people, 5.68%)
  19. Esomeprazole Sodium (5 people, 5.68%)
  20. Magnesium Sulfate (5 people, 5.68%)

Drug effectiveness *:

Glutathione:
  • not at all: 0 %
  • somewhat: 33.33 %
  • moderate: 66.67 %
  • high: 0 %
  • very high: 0 %

* Some reports may have incomplete information.


How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drug side effects in long term, by gender and age:

Treatments, associated medications and conditions:

Drug side effects:

Drugs that are associated with:

Conditions that are associated with:

How the phase IV clinical study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: